Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease

References

• Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol 2002; 23: 113–5
   PubMed Web of Science ®Google Scholar
• Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999; 190: 1697–710
   PubMed Web of Science ®Google Scholar
• Stohl W. B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr Rheumatol Rep 2002; 4: 345–50
   PubMedGoogle Scholar
• Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005; 11511: 3083–92
   Web of Science ®Google Scholar
• Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 2003; 62: 168–71
   PubMed Web of Science ®Google Scholar
• Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S, et al. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 2006; 54: 192–201
   PubMed Web of Science ®Google Scholar
• Fabris M, Quartuccio L, Sacco S, de Marchi D, Pozzato G, Mazzaro C, et al. B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford) 2007; 46: 37–43
   PubMed Web of Science ®Google Scholar
• Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001; 97: 198–204
   PubMed Web of Science ®Google Scholar
• Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192: 1453–66
   PubMed Web of Science ®Google Scholar
• Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002; 3: 822–9
   PubMed Web of Science ®Google Scholar
• Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, et al. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005; 174: 5537–44
   PubMed Web of Science ®Google Scholar
• Ohata J, Zvaifler NJ, Nishio M, Boyle DL, Kalled SL, Carson DA, et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005; 174: 864–70
   PubMed Web of Science ®Google Scholar
• Krumbholz M, Theil D, Derfuss T, Rosenala A, Schrader F, Monoranu CM, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005; 201: 195–200
   PubMed Web of Science ®Google Scholar
• Ittah M, Miceli-Richard C, Eric Gottenberg J, lavie F, lazure T, Ba N, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 2006; 8: R51
   PubMed Web of Science ®Google Scholar
• Rodrigo L. Celiac disease. World J Gastroenterol 2006; 12: 6585–93
   PubMed Web of Science ®Google Scholar
• Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517–24
   PubMed Web of Science ®Google Scholar
• Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, et al. Mass screening for coeliac disease using anti-human transglutaminase antibody assay. Arch Dis Child 2004; 89: 512–5
   PubMed Web of Science ®Google Scholar
• Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. JPGN 2005; 40: 1–19
   Google Scholar
• Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910–22
   PubMed Web of Science ®Google Scholar
• Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997; 49: 29–34
   PubMedGoogle Scholar
• Molberg Ø, Solheim Flaete N, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, et al. Intestinal T-cell response to high-molecular-weight glutenins in celiac disease. Gastroenterology 2003; 125: 337–44
   PubMed Web of Science ®Google Scholar
• Vader W, Stepniak D, Kooy Y, Mearin ML, Thompson A, Spaenij L, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to magnitude and breadth of gluten-specific T-cell response. Prot Natl Acad Sci USA 2003; 100: 12390–5
   PubMed Web of Science ®Google Scholar
• Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005; 129: 1294–301
   PubMed Web of Science ®Google Scholar
• Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity. Baillière's Clin Gastroenterol 1995; 9: 273–93
   PubMed Web of Science ®Google Scholar
• Obberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardization report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185–94
   PubMed Web of Science ®Google Scholar
• Catassi C, Fabiani E. The spectrum of celiac disease in children. Baillière's Clin Gastroenterol 1997; 11: 485–507
   PubMed Web of Science ®Google Scholar
• van Heel DA, West J. Recent advances in coeliac disease. Gut 2006; 55: 1037–46
   PubMed Web of Science ®Google Scholar
• Tonutti E, Visentini D, Bizzaro N, Caradonna M, Cerni L, Villalta D, et al. The role of anti-tissue transglutaminase assay for the diagnosis and monitoring of celiac disease. J Clin Pathol 2003; 56: 389–93
   PubMed Web of Science ®Google Scholar
• Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serological tests for celiac disease: a systematic review. Gastroenterology 2005; 128: S38–46
   PubMed Web of Science ®Google Scholar
• Brar P, Kwon GY, Egbuna II, Holleran S, Ramakrishnan R, Bhagat G, et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of celiac disease. Dig Liver Dis 2007; 39: 26–9
   PubMedGoogle Scholar
• Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801
   PubMed Web of Science ®Google Scholar
• van Meensel B, Hiele M, Hoffman I, Vermeire S, Rutgeerts P, Geboes K, et al. Diagnostic accuracy of ten second-generation (human) tissue transglutaminase autoantibody assays in celiac disease. Clin Chem 2004; 50: 2125–35
   PubMed Web of Science ®Google Scholar
• Kaukinen K, Mäki M, Partanen J, Sievänen H, Collin P. Celiac disease without villous atrophy. Revision of criteria called for. Dig Dis Sci 2001; 46: 879–87
   PubMed Web of Science ®Google Scholar
• Simell S, Kupila A, Hoppu S, Hekkala A, Simell T, Ståhlberg M-R, et al. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol 2005; 40: 1182–91
   PubMed Web of Science ®Google Scholar
• Scoglio R, Di Pasquale G, Pagano G, Lucanto MC, Magazzu G, Sferlazzas C. Is intestinal biopsy always needed for diagnosis of celiac disease?. Am J Gastroenterol 2003; 98: 1325–31
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Inchingolo CD, Monardo E, et al. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten free diet: a 2-year prospective study. Endoscopy 2006; 38: 702–7
   PubMed Web of Science ®Google Scholar
• Hakanen M, Luotola K, Salmi J, Laippala P, Kaukinen K, Collin P. Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 2001; 46: 2631–5
   PubMed Web of Science ®Google Scholar
• Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000; 137: 263–5
   PubMed Web of Science ®Google Scholar
• Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves’ disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 2006; 147: 4561–8
   PubMed Web of Science ®Google Scholar
• Celier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356: 203–8
   PubMed Web of Science ®Google Scholar
• Cerf-Bensussan N, Brousse N, Cellier C. From hyperplasia to cell lymphoma. Gut 2002; 51: 304–5
   PubMed Web of Science ®Google Scholar
• Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 2006; 18: 284–9
   PubMed Web of Science ®Google Scholar
• Shivakumar L, Ansell S. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies. Clin Lymphoma Myeloma 2006; 7: 106–8
   PubMedGoogle Scholar